GlassScriptPhysician profile
Stuart D Cope
NPI 1194240663
$7,312.47
in general payments reported to CMS, 2019-2025
37 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $970 · 2023: $1,661 · 2024: $2,030 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,056.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $954.60 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $812.35 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $608.69 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $544.54 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $410.06 | 2022-2025 | |
| Kerecis Limited | $404.97 | 2021-2022 | |
| Smith+Nephew, INC. | $404.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $348.19 | 2022-2025 | Farxiga, Lokelma |
| Alnylam Pharmaceuticals INC. | $298.52 | 2024-2025 | Onpattro |
| Boston Scientific Corporation | $265.18 | 2022-2025 | Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $238.97 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $227.78 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $224.10 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Lexicon Pharmaceuticals, INC. | $197.18 | 2023-2024 | Inpefa |
| Pfizer INC. | $191.69 | 2023-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $169.99 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $166.61 | 2024 | Arcalyst |
| Philips North America LLC | $137.85 | 2023-2025 | Ecc Solutions, Mcot, Extended Holter |
| Sanofi-Aventis U.S. LLC | $129.93 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $67.24 | 2025 | Verquvo, Winrevair, Capvaxive |
| Bridgebio Pharma, INC. | $66.92 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $44.81 | 2025 | |
| Medtronic, INC. | $42.32 | 2022-2023 | Cobalt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $37.70 | 2025 | Evoque |
| Abiomed | $37.50 | 2025 | |
| Scpharmaceuticals INC. | $37.38 | 2023-2024 | |
| Esperion Therapeutics, INC. | $34.64 | 2022-2023 | Nexletol |
| Lilly USA, LLC | $32.77 | 2024-2025 | Zepbound, Jardiance |
| Inspire Medical Systems, INC. | $25.13 | 2025 | Inspire |
| Zoll Circulation INC | $25.00 | 2022 | |
| Cmp Pharma, INC. | $21.69 | 2023 | Tadliq, Carospir, Norliqva |
| Bioventus LLC | $21.09 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.96 | 2022 | |
| Surmodics, INC. | $17.64 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Bsn Medical INC | $17.09 | 2022 | |
| Angiodynamics, INC. | $14.57 | 2023 | Alphavac |
| Kci USA, INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.